Intervet / Schering Plough Animal Health at VIV Europe in Moscow.
RUSSIA - Animal health company Intervet / Schering Plough Animal Health is to present the new combined company to a large audience for the first time at the VIV Europe in Moscow.

Intervet/Schering-Plough Animal Health Appoints Executive Team
THE NETHERLANDS – Schering-Plough appointed the Executive Team members of the company’s global animal health unit: Intervet / Schering- Plough Animal Health. These appointments define the major steps in the design process of the animal health unit. The...

Sponsored Walk and Climb
UK - John Richardson from Intervet will be one of a group of eight people, who are doing a sponsored 73 mile walk in June, from Inverness to Fort William, and then climbing Ben Nevis.

Intervet opens new FMD vaccine facility
BOXMEER – Intervet, the largest vaccine producer world-wide, has opened a new formulation and filling unit at the Foot and Mouth Disease (FMD) vaccine factory in Cologne, Germany. With this factory Intervet substantially strengthens its worldwide position...

Dieter Lutticken Award Winner
UK - The annual Dieter Lütticken Award, has been granted to Dr Mark Stevens from the Institute of Animal Health, United Kingdom for his commitment to advancing the 3R concept – reducing, refining or replacing the use of animals in research.

Intervet sees 6% global growth
THE NETHERLANDS - Revenues at Intervet increased by 3% to EUR 1,125 million boosted by strong autonomous growth of 6% across all regions and product lines.

Intervet opens new vaccine plant
THE NETHERLANDS – Intervet, the world’s largest producer of vaccines for animals, has just opened a new production facility for vaccines in Boxmeer, the Netherlands.

Intervet appoints Ellen de Brabander as a member of the company’s Executive Committee
THE NETHERLANDS - Intervet, Akzo Nobel’s veterinary pharma business, announces that Ellen de Brabander – van den Berg (43) has been appointed as a member of Intervet’s Executive Committee, effective October 1, 2006. Ellen de Brabander will succeed Klaus...

Revolutionary new tool: the IDAL Vaccinator
THE NETHERLANDS - Intervet's IDAL Vaccinator is a revolutionary needleless vaccination device, that allows intradermal application of swine vaccines. Due to its unique nature it has a number of advantages over traditional vaccination techniques.

Intervet Satellite Symposium - IPVS 2006
DENMARK - Porcilis PRRS and the new Porcilis M Hyo are two of the spearhead products which Intervet arms you with to help to fight PRDC in pigs.

Investing In Health Closes The Door On Disease
UK - Most producers associate PRRS or Blue Ear disease with the breeding herd - a virus that causes reproductive failure, poor litter sizes and low piglet viability. However, the damage PRRS can do to the finishing herd is equally, if not more costly....

Foot-and-Mouth disease vaccine factory now owned by Intervet
THE NETHERLANDS - Five months after signing an agreement on sale and purchase the Foot-and-Mouth (FMD) vaccine factory in Cologne Bayer HealthCare AG and Intervet International bv have completed the acquisition.

Intervet Satellite Symposium - IPVS 2006
DENMARK - Porcilis PRRS and the new Porcilis M Hyo are two of the spearhead products which Intervet arms you with to help to fight PRDC in pigs.

Akzo Nobel BV to separate Pharma from its Chemicals/Coatings businesses
THE NETHERLANDS – Akzo Nobel NV has announced today that it intends to separate its pharmaceutical activities from its chemicals and coatings businesses. The aim is to create two independent companies that are each a platform for growth in their own ...

Intervet acquires FMD vaccine factory from Bayer HealthCare AG
THE NETHERLANDS – Intervet, the animal health business unit of Akzo Nobel, announced the agreement with Bayer HealthCare AG to acquire the Foot and Mouth Disease (FMD) vaccine factory in Cologne, Germany.

Intervet updates Porcilis PRRS web site.
THE NETHERLANDS - In 1987 Porcine Reproductive and Respiratory Syndrome (PRRS) was first observed in pig herds in the United States. In 1990 the first case of PRRS was reported in Europe. By the early 1990s PRRS become pandemic.

Dutch Ministry banks Intervet's Classical Swine Fever vaccine
THE NETHERLANDS - On 28th of September 2005 the Dutch Ministry of Agriculture signed a contract with Intervet agreeing a vaccine bank of Porcilis Pesti, Intervet's marker vaccine against Classical Swine Fever.

Porcilis PRRS now available for Spanish sows
UK - Intervet Spain hosted an international seminar in Madrid to mark the newly obtained marketing approval for the use of Porcilis PRRS in breeding stock.

New Glãsser Disease Vaccine - the first to have full regulatory approval
UK - Porcilis Glãsser vaccine will be launched in the UK in November 2004. This is the first Glässer's Disease vaccine to pass the full EU regulatory standards and it has a pan-European licence.